跳至主要内容
临床试验/NCT03139877
NCT03139877已完成不适用

Pediatric Obesity Observational Prospective Trial: Microbiome and Metabolism During Obesity Target Therapeutics

Duke University1 个研究点 分布在 1 个国家目标入组 295 人开始时间: 2016年9月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
295
试验地点
1
主要终点
Change in Body Mass Index (kg/m2)

研究概览

简要总结

Using an observational case-control cohort design, the investigator aims to define the mechanisms underlying microbiome regulation of metabolism in adolescence before and after medically indicated therapies for obesity. The investigator's overarching hypothesis is that gut bacteria control host weight, insulin sensitivity, and response to weight-loss treatments by modifying host metabolism.

详细描述

Intervention Cohorts: A prospective, longitudinal observational case control study will be performed. All subjects will receive Healthy Lifestyle Program (HLP) standard of care, which includes intensive lifestyle modification and free participation in Bull City Fit. Four groups of participants receiving obesity treatment will be enrolled: (1) HLP-only, (2) HLP + Low carbohydrate diet, (3) HLP + weight loss medication(s) and (4) HLP + Bariatric surgery. Consistent with the observational design of this study, study participants will be assigned to each group as per usual HLP clinical care, based on established standards and guidelines, expert medical provider recommendations, and family preference.

Comparison Cohort: two comparison groups be enrolled:(1c) healthy siblings of enrolled intervention subjects and (2c) age/sex matched controls recruited from the Duke Children's Primary Care Clinic.

Up to 350 participants will be enrolled, with the goal of 295 evaluable participant data. The study period is six months for all groups with the exception of the bariatric surgery group which will last from baseline until after surgery, up to 12 months. The comparison groups will have one visit at baseline only.

Stool Sample Collection: Participants in both intervention and comparison groups will provide a fecal sample at enrollment or within 3 days of enrollment. Participants in intervention groups (Groups 1-4) will provide additional fecal samples at 1.5, 3, 4.5, and 6 months. Given that the ability to collect fecal samples is unpredictable, the investigator will develop a standard operating procedure along the following guidelines:

  1. At the first visit, if the subject cannot provide a sample at the time of enrollment, the investigator will give the participant/parent a cooler/ice pack and sample collection kit. The investigator will ask the subject to provide the "baseline" sample within 3 days of the first visit. The sample will be refrigerated for up to 24 hours prior to pick up by the clinical research staff or delivery by the parent/guardian, with compensation for miles. With pick up or delivery a new cooler and freezer pack as well as sample collection kit will be provided for the following sample collection.
  2. Within a 2-week window, centered on collection points 1.5 and 4.5 months, the subjects will provide additional samples. They may either have the samples picked up within 24 hours of collection (with refrigeration from collection to pick up) or get reimbursed for mileage.
  3. For the 3-month and 6-month collections, which occur in conjunction with a regularly scheduled Healthy Lifestyles visit, the patients will collect a sample within 24 hours prior to the visit and bring with them to clinic. At the 3-month visit they will be sent home with new collection kits, freezer packs, and coolers.
  4. If a patient cannot provide a sample within 24 hours of a clinic visit or a sample is missed, we will still collect a sample as soon as the patient is able to provide it and arrange for pickup or delivery as outlined below, noting the sample as "out of window."

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
10 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Child aged 10-18 years
  • Sexual Maturity Rating 2 or above (pubertal)
  • Age- and gender-specific BMI ≥ 95th percentile
  • Expected enrollment in Healthy Lifestyles Clinical Program > 6 months

排除标准

  • Antibiotic use in the 1 month prior to expected enrollment
  • Anticipated antibiotic use during the course of the study.
  • Immunodeficiency or prior transplantation
  • Type 1 diabetes mellitus
  • Inborn error of metabolism
  • No fluency in English or Spanish
  • Identifiable cause of obesity including hypothyroidism, Cushing syndrome, known genetic obesity syndrome including melanocortin receptor 4 mutation, drug-induced obesity including steroids or anti-psychotics
  • Significant medical or mental health condition that precludes treatment
  • Receiving insulin
  • Plans to move away from area in next 6 months
  • Weight loss of >5% total body weight in prior 3 months
  • Pregnancy (self-report, confirm with noted last menstrual period in chart)
  • Home outside of a 50 mile radius from the HL Clinic.

结局指标

主要结局

Change in Body Mass Index (kg/m2)

时间窗: Baseline and 6 months

We will measure weight (in kilograms) and height (in cm) for all subjects at baseline and at 6 months (12 months for the surgery group). The between-group difference in Body Mass Index change will be reported.

次要结局

  • Change in blood metabolites(Baseline, 3 months and 6 months)
  • Change in blood pressure(Baseline and 6 months)
  • Change in cardiovascular fitness(Baseline and 6 months)
  • Change in fasting blood cholesterol(Baseline and 6 months)
  • Change in fasting blood glucose(Baseline and 6 months)
  • Change in stool microbiota profile(Baseline and every 6 weeks up to 6 months (0m, 1.5m, 3m, 4.5m, 6m))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验